Seres Therapeutics, Inc. (MCRB)
NASDAQ·Healthcare·Biotechnology
$5.34
+6.16%
Mkt Cap $83.09M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.25
Range $1.25 – $1.25
Implied Upside
-76.6%
Consensus $1.25 vs current $5.34
NASDAQ·Healthcare·Biotechnology
$5.34
+6.16%
Mkt Cap $83.09M
No recent rating data.
Price Target (1 analysts)
$1.25
Range $1.25 – $1.25
-76.6%
Consensus $1.25 vs current $5.34